Amgen’s Uplizna (inebilizumab-cdon) has been approved by the US Food and Drug Administration (FDA) as the first treatment for ...

AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved by the European Commission (EC) to ...

The robots aren’t taking over One commonly held view, thank goodness, is that AI is not going to take over and make us all ...

Novartis’ Vanrafia (atrasentan) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat ...

A report by MedCity ranks London as the number one city in Europe and the third city globally for life sciences. The Global ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

Medscape, a global leader in infectious disease education, continues its commitment to advancing knowledge in the field. With ...

Virtual publication planning is rapidly evolving with new digital tools, but are you truly optimizing your strategy? Our ...

Genmab has announced that the European Commission (EC) has approved Tivdak (tisotumab vedotin) to treat recurrent or ...

Organon and Shanghai Henlius Biotech have announced that the European Medicines Agency (EMA) has validated a marketing ...

AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug ...

Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended Adcetris ...